2,4-Dihydro-4[4-[4-[4-Hydroxyphenyl]-1-piperazinyl]Phenyl]-2-(1-Methylpropyl)-3H-1,2,4-Triazole-3-One

106461-41-0 2,4-Dihydro-4[4-[4-[4-Hydroxyphenyl]-1-piperazinyl]Phenyl]-2-(1-Methylpropyl)-3H-1,2,4-Triazole-3-One 98%

Price	Get Latest Price
Packge	1kg	5kg	10kg	25kg

Min. Order:10kg
Time:2024-01-05

Product Details

Product Name2,4-Dihydro-4[4-[4-[4-Hydroxyphenyl]-1-piperazinyl]Phenyl]-2-(1-Methylpropyl)-3H-1,2,4-Triazole-3-One
CAS No.106461-41-0
EINECS No.434-820-9
MFC22H27N5O2
MW393.48
AppearanceSolidOff-White Pale Brown
Melting point 177-179°C
storage temp. Sealed in dry,Room Temperature
Boiling point 587.9±60.0 °C(Predicted)
density 1.25±0.1 g/cm3(Predicted)

Company Profile Introduction

We are an integrated pharmaceutical company with a strong portfolio of niche formulations, APIs and advanced intermediates Viyash and its subsidiaries operate 10 API / Intermediate facilities with a combined capacity ~2000 KL and diversified capabilities in every aspect - small / large volume, potent / non-potent, regulated / semi-regulated markets.

In addition, we also operate one formulation manufacturing facility in New Jersey, USA with a capacity of ~ 1.2 Bn units.

Leading from the front and staying honest about our origin mission, the two qualities associated with the Vedic interpretation of “Viyash”, are the propellers of success for any pharmaceutical initiative. We work professionally every day with a single-minded intent to build trust and honest relationships with our community and with our customers.

Our robust API and Formulations R&D infrastructure with a combined strength of over 200 scientists offers expertise across several technologies and complex reactions. Top that with a diversified mix of portfolio across multiple therapy areas such as ARV, CV, CNS, Analgesics, Antibiotics, Antihistamines, Diabetes, GI, Anticoagulants, Oncology etc., and you get the perfect Viyash potion.